Clinical Trial Update: Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen® [Phase 4]

View source ↗

Summary

Phase 4 trial in Chinese children with growth hormone deficiency evaluated predictive markers in Saizen (somatropin) treatment; the study is completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Saizen (somatropin)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Dwarfism, Pituitary | Phase 4 | Status: COMPLETED | Results posted: 2012-08-07